Middle East and Africa Oligonucleotide Synthesis Market

Middle East & Africa Oligonucleotide Synthesis Market Size

The Middle East & Africa Oligonucleotide Synthesis Market size was worth US$ 83.26 million in 2025, and is anticipated to be worth USD 205.50 million by 2034 from USD 92.05 million in 2026, growing at a CAGR of 10.56% during the forecast period.

MARKET DRIVERS AND RESTRAINTS

The Middle East and Africa are becoming increasingly popular hubs for various production industries and construction and the growth of Oligonucleotide market is growing primarily because of the various research and development activities taking part in the MEA nations.

Synthesized oligonucleotides have various applications in the life sciences, pharmaceuticals, and probing of DNA synthesis and sequencing.
Clinical trials involving humans are also becoming increasingly popular in the Middle East and African region, which triggered a demand for the Oligonucleotide industry. Gene editing, drug recovery, data storage, and synthetic biology are a few sectors in which oligos are used, thus the development of these sectors has led to the growth of the oligonucleotide synthesis industry in this area.

Covid-19 had a measurable impact on all end-users, including the construction and production segments, halting all production activities. In addition, the oligonucleotide synthesis procedure is relatively expensive. This cost ineffectiveness is also acting as a serious threat that hinders business expansion in the MEA.

On top of this, the healthcare sector is not as robust in the Middle East and African region as compared to North America or Europe, therefore in this respect, the oligonucleotide industry lags behind.

This research report on the Middle East & Africa Oligonucleotide Synthesis market has been segmented and sub-segmented into the following categories.

Middle East & Africa Oligonucleotide Synthesis Market By Product

• Primers
• Probes
• Linkers
• Adaptors
• Custom
• Reagent
• Equipment

Middle East & Africa Oligonucleotide Synthesis Market By Application

• DNA
• PCR
• RNAi
• Research
• Therapeutics

Middle East & Africa Oligonucleotide Synthesis Market By End-Use

• Biotechnology
• Pharmaceutical
• Academic
• Hospital and Lifesciences

The oligos are used as microarrays or gene panels which proves to be helpful in hybridization and proves to be useful in therapeutic applications.

Oligonucleotide synthesis found a wide range of applications in the medical sector for research purposes such as DNA synthesis probes and sequencing. Probes are used for the detection of complementary RNA and DNA through hybridization in clinical developments and the synthesis of artificial genes.

KEY MARKET PLAYERS

Agilent Technologies, Inc., Quintara Biosciences, Twist Bioscience, Bio-Synthesis Inc., Eurofins Genomics, Kaneka Eurogentec S.A., General Electric are some of the notable companies in the Middle East and African Oligonucleotide Synthesis market.